NCT05898646 - Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

AL Amyloidosis

Interventions

PROCEDURE

Bone Marrow Aspiration

Undergo bone marrow aspiration

BIOLOGICAL

Daratumumab

Given SC

PROCEDURE

Echocardiography Test

Undergo echocardiography

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

X-Ray Imaging

Undergo x-ray imaging

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

Trial Locations (2)

RECRUITING

Mayo Clinic in Rochester, Rochester

RECRUITING

Mayo Clinic in Arizona, Scottsdale